We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · February 11, 2020

Immuno-Oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous Cell Carcinoma of the Bladder

European Urology


Additional Info

Disclosure statements are available on the authors' profiles:

European Urology
Comprehensive Assessment of Immuno-Oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-Cell Carcinoma of the Bladder
Eur Urol 2020 Jan 17;[EPub Ahead of Print], A Necchi, R Madison, D Raggi, JM Jacob, G Bratslavsky, O Shapiro, JA Elvin, JA Vergilio, JK Killian, N Ngo, S Ramkissoon, E Severson, AC Hemmerich, R Huang, SM Ali, JH Chung, P Reddy, VA Miller, AB Schrock, LM Gay, BM Alexander, P Grivas, JS Ross

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading